Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Will Omicron finally overpower China’s COVID defences?

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout

Nature 604, 17-18 (2022)


Updates & Corrections

  • Correction 30 March 2022: An earlier version of this story incorrectly attributed the rates of vaccination in people over 80 on the Chinese mainland to an Airfinity report rather than the Chinese government. This has been corrected.


  1. McMenamin, E. et al. Preprint at medRxiv (2022).

Download references


Nature Careers


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links